Balaxi Pharmaceuticals Ltd

BALAXI
Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹437 cr, stock is ranked 1,320
Moderate RiskStock is 2.77x as volatile as Nifty
426.6010.65 (-2.44%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareHealth Care Equipment & Supplies
SmallcapWith a market cap of ₹437 cr, stock is ranked 1,320
Moderate RiskStock is 2.77x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
9.17
PB RatioPB Ratio
6.73
Dividend YieldDiv. Yield
0.11%
Sector PESector PE
32.23
Sector PBSector PB
4.77
Sector Div YldSctr Div Yld
0.86%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The company is engaged in wholesale trading of pharmaceuticals products, food products and builders’ hardware products. The Company offers a range of food and biscuit products under the brand name YAP.

Investor PresentationView older 

Feb 15, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201920202021202214.4946.22233.56284.361.986.0938.1347.67
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Newspaper Advertisements 
Announced OnMay 24, 2022

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Newspaper Advertisements | Download

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Newspaper Advertisements | Download

Press Release 
Announced OnMay 23, 2022

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about press release dated 23-May-2022 titled Balaxi Pharmaceuticals reports continued solid growth in Q4 and FY22¬タン | Download

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about press release dated 23-May-2022 titled Balaxi Pharmaceuticals reports continued solid growth in Q4 and FY22¬タン | Download

Communication to shareholders as per Reg 30 
Announced OnMay 23, 2022

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about setting up of its first manufacturing plant as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | Download

BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about setting up of its first manufacturing plant as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | Download

See all events